Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLN
12176
PUT
Silence Therapeutics
SLN
$648M
| $36.4K | ﹤0.01% |
+2,000
| New | +$37.2K |
|
12177
TELA Bio
TELA
$28.9M
| $36.3K | ﹤0.01% |
14,362
-175,341
| -92% | -$624K |
|
|
ATXS
12178
PUT
DELISTED
Astria Therapeutics
ATXS
| $36.3K | ﹤0.01% |
3,300
-23,900
| -88% | -$266K |
|
|
VERV
12179
CALL
DELISTED
Verve Therapeutics
VERV
| $36.3K | ﹤0.01% |
7,500
-4,900
| -40% | -$28.5K |
|
12180
PUT
Fulton Financial
FULT
$4.72B
| $36.3K | ﹤0.01% |
2,000
+1,400
| +233% | +$25.5K |
|
|
NINE
12181
DELISTED
Nine Energy Service
NINE
| $36.3K | ﹤0.01% |
32,088
-20,588
| -39% | -$29.3K |
|
|
NOTV
12182
PUT
DELISTED
Inotiv
NOTV
| $36.2K | ﹤0.01% |
21,300
+8,400
| +65% | +$14.2K |
|
12183
PUT
Credicorp
BAP
$30.7B
| $36.2K | ﹤0.01% |
200
-500
| -71% | -$85.3K |
|
|
ARC
12184
PUT
DELISTED
ARC Document Solutions, Inc.
ARC
| $36.2K | ﹤0.01% |
10,700
+10,200
| +2,040% | +$31.9K |
|
12185
PUT
OPAL Fuels
OPAL
$65.3M
| $36.1K | ﹤0.01% |
9,900
-13,200
| -57% | -$49.7K |
|
12186
NextPlat
NXPL
$22.4M
| $36.1K | ﹤0.01% |
+2,559
| New | +$30.7K |
|
|
NKGN
12187
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $36.1K | ﹤0.01% |
+95,438
| New | +$84.7K |
|
12188
Cheche Group
CCG
$42.4M
| $36.1K | ﹤0.01% |
+1,134
| New | +$33K |
|
12189
Imunon
IMNN
$9.26M
| $36K | ﹤0.01% |
+2,606
| New | +$41.3K |
|
12190
Babcock & Wilcox
BW
$1.53B
| $35.9K | ﹤0.01% |
17,621
-440,378
| -96% | -$625K |
|
12191
PUT
Inogen
INGN
$153M
| $35.9K | ﹤0.01% |
3,700
+3,600
| +3,600% | +$37.8K |
|
|
TBHC
12192
DELISTED
The Brand House Collective
TBHC
| $35.9K | ﹤0.01% |
+16,385
| New | +$27.5K |
|
12193
CALL
Afya
AFYA
$1.27B
| $35.8K | ﹤0.01% |
2,100
+1,200
| +133% | +$20.8K |
|
12194
CALL
Definitive Healthcare
DH
$68.2M
| $35.8K | ﹤0.01% |
8,000
-35,000
| -81% | -$164K |
|
12195
CALL
Peapack-Gladstone Financial
PGC
$828M
| $35.6K | ﹤0.01% |
1,300
+200
| +18% | +$5.25K |
|
12196
CALL
ACI Worldwide
ACIW
$5.4B
| $35.6K | ﹤0.01% |
+700
| New | +$32K |
|
12197
PUT
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
| $35.6K | ﹤0.01% |
600
-1,600
| -73% | -$92.1K |
|
12198
CALL
SkinHealth Systems
SKIN
$86.8M
| $35.6K | ﹤0.01% |
24,700
-69,600
| -74% | -$114K |
|
12199
PUT
Legacy Housing
LEGH
$698M
| $35.6K | ﹤0.01% |
1,300
+500
| +63% | +$13.1K |
|
12200
CALL
Ondas Inc
ONDS
$5.27B
| $35.5K | ﹤0.01% |
46,100
+11,100
| +32% | +$9.11K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.